Research | Clinical Research
Advancing HIV Treatment, Prevention and Clinical Outcomes
Introduction
Clinical Research is one of the key research areas at the Rakai Health Sciences Program (RHSP), encompassing studies focused on HIV treatment, clinical outcomes and biomedical HIV prevention.
This research area brings together investigations into HIV-related clinical care and prevention interventions. Through clinical research, RHSP contributes to the generation of scientific evidence relevant to improving HIV prevention and treatment approaches.
RHSP's Clinical Research portfolio includes HIV Treatment and Clinical Outcomes (COE) and HIV Biomedical Prevention.
Ongoing Research
HIV Treatment and Clinical Outcomes (COE)
HIV Treatment and Clinical Outcomes (COE) is one of the ongoing research areas under RHSP's Clinical Research portfolio.
This area focuses on HIV treatment and clinical outcomes.
HIV Biomedical Prevention
HIV Biomedical Prevention is the second ongoing research area within RHSP's Clinical Research portfolio.
This area focuses on biomedical HIV prevention research.
Join us in our mission to advance health research and improve public health outcomes globally.
Collaborate for Health, Innovate for Impact.
